Thadani U - Search Results

1

Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.

Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH. Thadani U, et al. Ann Intern Med. 1994 Mar 1;120(5):353-9. doi: 10.7326/0003-4819-120-5-199403010-00001. Ann Intern Med. 1994. PMID: 8093132 Clinical Trial.

2

Duration of effects of isradipine during twice daily therapy in angina pectoris.

Thadani U, Chrysant S, Gorwit J, Giles T, Archer S, Iteld B, Singh S, Copen D, Wakeford C, Hobbs S. Thadani U, et al. Cardiovasc Drugs Ther. 1994 Apr;8(2):199-210. doi: 10.1007/BF00877328. Cardiovasc Drugs Ther. 1994. PMID: 7918132 Clinical Trial.

3

Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.

Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R, et al. Thadani U, et al. Circulation. 1991 Dec;84(6):2398-408. doi: 10.1161/01.cir.84.6.2398. Circulation. 1991. PMID: 1959195 Clinical Trial.

4

Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.

Thadani U, Bittar N. Thadani U, et al. Am J Cardiol. 1992 Aug 1;70(3):286-92. doi: 10.1016/0002-9149(92)90606-y. Am J Cardiol. 1992. PMID: 1632390 Clinical Trial.

5

Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.

Alpert JS, Kobrin I, DeQuattro V, Friedman R, Shepherd A, Fenster PE, Thadani U. Alpert JS, et al. Among authors: thadani u. Am J Cardiol. 1997 Apr 15;79(8):1025-30. doi: 10.1016/s0002-9149(97)00041-6. Am J Cardiol. 1997. PMID: 9114758 Clinical Trial.

6

Efficacy of isosorbide mononitrate in angina pectoris.

Thadani U, de Vane PJ. Thadani U, et al. Am J Cardiol. 1992 Nov 27;70(17):67G-71G. doi: 10.1016/0002-9149(92)90029-x. Am J Cardiol. 1992. PMID: 1449103 Review.

7

Mononitrates: defining the ideal long-acting nitrate.

Frishman WH, Amsterdam E, Glasser SP, Thadani U. Frishman WH, et al. Among authors: thadani u. Clin Ther. 1994 Mar-Apr;16(2):130-9; discussion 129. Clin Ther. 1994. PMID: 7914830 Review.

8

Nitrate therapy and the development of tolerance.

Thadani U. Thadani U. Arch Fam Med. 1993 Aug;2(8):880-5. doi: 10.1001/archfami.2.8.880. Arch Fam Med. 1993. PMID: 8141915 Review.

9

Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group.

Kalbfleisch JM, Kurnik PB, Thadani U, DeWood MA, Kent R, Magorien RD, Jain AC, Spaccavento LJ, Morris DL, Taylor GJ, et al. Kalbfleisch JM, et al. Among authors: thadani u. Am J Cardiol. 1993 Feb 15;71(5):386-92. doi: 10.1016/0002-9149(93)90437-h. Am J Cardiol. 1993. PMID: 8430624 Clinical Trial.

10

Role of nitrates in angina pectoris.

Thadani U. Thadani U. Am J Cardiol. 1992 Sep 24;70(8):43B-53B. doi: 10.1016/0002-9149(92)90593-n. Am J Cardiol. 1992. PMID: 1529926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page